期刊文献+

大鼠血浆中环丙沙星的HPLC荧光分析检测法及其体内药物动力学研究 被引量:1

HPLC determination of ciprofloxacin with fluorescence detection in rat plasma and its pharmacokinetics study
下载PDF
导出
摘要 建立测定大鼠血浆中环丙沙星的RP HPLC荧光检测法和研究其体内的药物动力学。以格帕沙星为内标 ,血浆样品经乙腈沉淀蛋白 ,取上清夜进行HPLC检测。流动相为 0 0 5mol/L磷酸盐缓冲液( pH3 0 )—乙腈—甲醇 ( 77∶13∶10 ,v/v/v) ,荧光检测 ,λEX=2 76nm ,λEM=448nm。血浆样品在 0 0 0 2 5~ 0 5μg/ml范围内线性关系良好 ,平均提取回收率为 97 1% ,日间和日内精密度RSD均小于 8 0 % ,最低检测限达到 1 0ng/ml。环丙沙星在大鼠体内的过程符合双隔室开放型一级吸收动力学模型、药动学参数分别为 :T1/2(ka) =0 44h ,T1/2 (α) =0 92h ,T1/2 ( β) =5 6 6h ,Tmax=1 0 4h ,Cmax=0 35 μg/ml,AUC =1 86h·μg/ml。 A sensitive and rapid RP-HPLC method with fluorescence detection was developed to determine ciprofloxacin in rat plasma and its pharmacokinetics was also investigated. Grepafloxacin was used as an internal standard, the deproteinization by acetonitrile was proposed to deal with plasma samples and supernatants were subject to HPLC. The mobile phase consisted of 0.05mol/L phosphate buffer (pH3.0), acetonitrile and methanol (77∶13∶10, v/v/v). The fluorescence detection λ EX 276 nm and λ EM 448 nm were used. The good linearity with the range from 0.0025 to 0.5μg/ml was achieved. The average extraction recovery rate was 97.1% and RSD of the same-day and between-days was<8.0%. The lowest detection limit was 1.0 ng/ml . The time course of mean plasma concentrations was simulated by 3p87 program and conformed to two compartments with first-rate absorption kinetics process. The estimated main pharmacokinetics parameters were as follows: T 1/2 (Ka)=0.44 h, T 1/2 (α)=0.92 h, T 1/2 (β)=5.66 h, T max =1.04 h, C max =0.35μg/ml, AUC=1.86 h·μg/ml.
机构地区 沈阳药科大学
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2002年第10期625-627,640,共4页 Chinese Journal of Antibiotics
关键词 环丙沙星 RP-HPLC荧光检测法 大鼠体内药物动力学 Ciprofloxacin RP-HPLC with a fluorescence detection Rats pharmacokinetics
  • 相关文献

参考文献5

二级参考文献8

  • 1孟娟如.大白鼠颈静脉及肝门静脉持久性导管术及其应用[J].药学学报,1987,22(5):326-329.
  • 2戴自英,实用抗菌药物学,1992年
  • 3Wise R, Andrew JM, Brenwald N. The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone [J]. J Antimicrob Chemother, 1993,31:497-504.
  • 4Wakebe H, Mitsuhashi S. Comparative in vitro activities of a new quinolone, OPC-17116, possessing potent activities against gram-positive bacteria [J]. Antimicrob Agents Chemother, 1992,36:2185-2191.
  • 5Ito T, Yano I, Masuda S, et al. Distribution characteristics of levofloxacin and grepafloxacin in rat kidney [J]. Pharm Res, 1999, 16:534-539.
  • 6Taira K, Koga H, Kohno S. Accumulation of a newly developed fluroquinolone, OPC-17116, by human polymorphonuclear leukocytes [J].Antimicrob Agents Chemother, 1993,37:1877-1881.
  • 7Efthymiopoulos C,Bramer SL, Maroli A. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males [J].Clin Pharmacokinet, 1997,33(Suppl 1):1-8.
  • 8林赴田,余兰香,于锋,许嘉齐,熊雁琼,宋坤改,刘京芳.环丙氟哌酸的药效学和毒理学研究[J].中国抗生素杂志,1990,15(4):302-307. 被引量:17

共引文献37

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部